{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:58:45Z","timestamp":1790283525312,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.humpath.2026.106270","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:16:02Z","timestamp":1790205362000},"page":"106270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["RAS\/RAF\/MAPK alterations in prostatic adenocarcinoma: A multi-institutional study"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3660-5135","authenticated-orcid":false,"given":"Garrett J.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1793-2732","authenticated-orcid":false,"given":"Jung Woo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Tjota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4898-8911","authenticated-orcid":false,"given":"Dane R.","family":"Wuori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Korentzelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6623-9514","authenticated-orcid":false,"given":"Maedeh","family":"Mohebnasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1783-1711","authenticated-orcid":false,"given":"Nancy Y.","family":"Greenland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley A.","family":"Stohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffry P.","family":"Simko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9047-0222","authenticated-orcid":false,"given":"Chien-Kuang Cornelia","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0848-4172","authenticated-orcid":false,"given":"Deepika","family":"Sirohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.humpath.2026.106270_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106270_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","article-title":"Recent global patterns in prostate cancer incidence and mortality rates","volume":"77","author":"Culp","year":"2020","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.humpath.2026.106270_bib3","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/ijc.22071","article-title":"BRAF and KRAS mutations in prostatic adenocarcinoma","volume":"119","author":"Cho","year":"2006","journal-title":"Int J Cancer"},{"issue":"19","key":"10.1016\/j.humpath.2026.106270_bib4","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1158\/1078-0432.CCR-23-1393","article-title":"Unique spectrum of activating BRAF alterations in prostate cancer","volume":"29","author":"Chehrazi-Raffle","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.humpath.2026.106270_bib5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41588-018-0078-z","article-title":"The long tail of oncogenic drivers in prostate cancer","volume":"50","author":"Armenia","year":"2018","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.humpath.2026.106270_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010198","article-title":"Targeting aberrant RAS\/RAF\/MEK\/ERK signaling for cancer therapy","volume":"9","author":"Degirmenci","year":"2020","journal-title":"Cells"},{"issue":"21","key":"10.1016\/j.humpath.2026.106270_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215306","article-title":"The predictive and prognostic role of RAS-RAF-MEK-ERK pathway alterations in breast cancer: revision of the literature and comparison with the analysis of cancer genomic datasets","volume":"14","author":"Rocca","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.humpath.2026.106270_bib8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13045-024-01631-9","article-title":"RAS signaling in carcinogenesis, cancer therapy and resistance mechanisms","volume":"17","author":"Yang","year":"2024","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.humpath.2026.106270_bib9","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1016\/j.csbj.2021.06.007","article-title":"The mechanism of activation of monomeric B-Raf V600E","volume":"19","author":"Maloney","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"issue":"3","key":"10.1016\/j.humpath.2026.106270_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030666","article-title":"KRAS and RAS-MAPK pathway deregulation in mature B cell lymphoproliferative disorders","volume":"14","author":"Vendramini","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.humpath.2026.106270_bib11","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s43018-020-00125-0","article-title":"A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance","volume":"1","author":"Arriaga","year":"2020","journal-title":"Nat Cancer"},{"issue":"2","key":"10.1016\/j.humpath.2026.106270_bib12","doi-asserted-by":"crossref","first-page":"E172","DOI":"10.1073\/pnas.1521674112","article-title":"Functional screen identifies kinases driving prostate cancer visceral and bone metastasis","volume":"113","author":"Faltermeier","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.humpath.2026.106270_bib13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41416-026-03441-x","article-title":"Decoding the Raf-Mek-Erk-Rsk pathway in prostate cancer: from molecular mechanisms to clinical opportunities","volume":"135","author":"Waldron","year":"2026","journal-title":"Br J Cancer"},{"issue":"7915","key":"10.1016\/j.humpath.2026.106270_bib14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41586-022-04833-8","article-title":"Androgen receptor blockade promotes response to BRAF\/MEK-targeted therapy","volume":"606","author":"Vellano","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.humpath.2026.106270_bib15","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/his.14205","article-title":"Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases","volume":"77","author":"Alhamar","year":"2020","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.humpath.2026.106270_bib16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/his.14224","article-title":"PIN-like ductal carcinoma of the prostate has frequent activating RAS\/RAF mutations","volume":"78","author":"Kaur","year":"2021","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.humpath.2026.106270_bib17","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1177\/10668969241295687","article-title":"Unconventional histopathological features with KIAA1549::BRAF fusion in advanced prostatic adenocarcinoma","volume":"33","author":"Sharma","year":"2025","journal-title":"Int J Surg Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2026.106270_bib18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"269","key":"10.1016\/j.humpath.2026.106270_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"issue":"7","key":"10.1016\/j.humpath.2026.106270_bib21","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/PAS.0b013e318160edaf","article-title":"High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases","volume":"32","author":"Tavora","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.humpath.2026.106270_bib22","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/bjc.2011.163","article-title":"Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer","volume":"104","author":"Mukherjee","year":"2011","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.humpath.2026.106270_bib23","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1016\/j.clgc.2019.12.015","article-title":"Eradication of BRAF K601E mutation in metastatic castrate-resistant prostate cancer treated with cabazitaxel and carboplatin: a case report","volume":"18","author":"Steinwald","year":"2020","journal-title":"Clin Genitourin Cancer"},{"issue":"7","key":"10.1016\/j.humpath.2026.106270_bib24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm.2166","article-title":"Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma","volume":"16","author":"Palanisamy","year":"2010","journal-title":"Nat Med"},{"issue":"7153","key":"10.1016\/j.humpath.2026.106270_bib25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nature06024","article-title":"Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer","volume":"448","author":"Tomlins","year":"2007","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.humpath.2026.106270_bib26","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1158\/0008-5472.CAN-08-4926","article-title":"SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer","volume":"69","author":"Rickman","year":"2009","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.humpath.2026.106270_bib27","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.2353\/ajpath.2009.080776","article-title":"Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer","volume":"174","author":"Kuruma","year":"2009","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1016\/j.humpath.2026.106270_bib28","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1007\/s12094-022-02916-6","article-title":"MEK inhibitor sensitivity in BRAF fusion-driven prostate cancer","volume":"24","author":"Fenor","year":"2022","journal-title":"Clin Transl Oncol"},{"issue":"15","key":"10.1016\/j.humpath.2026.106270_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158100","article-title":"Elevated LAMTOR4 expression is associated with lethal prostate cancer and its knockdown decreases cell proliferation, invasion, and migration in vitro","volume":"25","author":"Gamallat","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.humpath.2026.106270_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.100983","article-title":"Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populations","volume":"50","author":"Hu","year":"2024","journal-title":"Neoplasia"},{"issue":"3","key":"10.1016\/j.humpath.2026.106270_bib31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ccell.2015.08.001","article-title":"BRAF mutants evade ERK-dependent feedback by different mechanisms that determine their sensitivity to pharmacologic inhibition","volume":"28","author":"Yao","year":"2015","journal-title":"Cancer Cell"},{"issue":"7666","key":"10.1016\/j.humpath.2026.106270_bib32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nature23291","article-title":"Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS","volume":"548","author":"Yao","year":"2017","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.humpath.2026.106270_bib33","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41417-021-00383-9","article-title":"The KRAS-G12C inhibitor: activity and resistance","volume":"29","author":"Liu","year":"2022","journal-title":"Cancer Gene Ther"},{"issue":"10","key":"10.1016\/j.humpath.2026.106270_bib34","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A comprehensive survey of Ras mutations in cancer","volume":"72","author":"Prior","year":"2012","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.humpath.2026.106270_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/2159-8274.CD-10-0022","article-title":"Characterization of KRAS rearrangements in metastatic prostate cancer","volume":"1","author":"Wang","year":"2011","journal-title":"Cancer Discov"},{"issue":"3","key":"10.1016\/j.humpath.2026.106270_bib36","first-page":"118","article-title":"Molecular and clinicopathological correlates of wild-type KRAS expression in prostate cancer","volume":"7","author":"Ebili","year":"2024","journal-title":"Ann Urol Oncol"},{"issue":"2","key":"10.1016\/j.humpath.2026.106270_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12032-016-0879-9","article-title":"KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma","volume":"34","author":"Cicenas","year":"2017","journal-title":"Med Oncol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106270_bib38","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41392-021-00780-4","article-title":"KRAS mutation: from undruggable to druggable in cancer","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"32","key":"10.1016\/j.humpath.2026.106270_bib39","doi-asserted-by":"crossref","first-page":"15823","DOI":"10.1073\/pnas.1904529116","article-title":"Drugging an undruggable pocket on KRAS","volume":"116","author":"Kessler","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"25","key":"10.1016\/j.humpath.2026.106270_bib40","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1056\/NEJMoa2103695","article-title":"Sotorasib for lung cancers with KRAS p.G12C mutation","volume":"384","author":"Skoulidis","year":"2021","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.humpath.2026.106270_bib41","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1158\/1078-0432.CCR-21-3074","article-title":"FDA approval summary: sotorasib for KRAS G12C-Mutated metastatic NSCLC","volume":"28","author":"Nakajima","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.humpath.2026.106270_bib42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2208470","article-title":"Sotorasib in KRAS p.G12C-Mutated advanced pancreatic cancer","volume":"388","author":"Strickler","year":"2023","journal-title":"N Engl J Med"},{"issue":"7406","key":"10.1016\/j.humpath.2026.106270_bib43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2026.106270_bib44","article-title":"Molecular testing in patients with castration-resistant prostate cancer and its impact on clinical decision making","volume":"1","author":"Tao","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"7","key":"10.1016\/j.humpath.2026.106270_bib45","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1128\/MCB.19.7.5143","article-title":"Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer","volume":"19","author":"Abreu-Martin","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.humpath.2026.106270_bib46","first-page":"279","article-title":"Activation of mitogen-activated protein kinase associated with prostate cancer progression","volume":"59","author":"Gioeli","year":"1999","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.humpath.2026.106270_bib47","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41391-019-0134-5","article-title":"MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer","volume":"22","author":"Nickols","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772600239X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772600239X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:59:25Z","timestamp":1790279965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681772600239X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":46,"alternative-id":["S004681772600239X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106270","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RAS\/RAF\/MAPK alterations in prostatic adenocarcinoma: A multi-institutional study","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106270","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106270"}}